Split History
ETFs Holding ABEO »    ABEO Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL™ clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM™ capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs. According to our ABEO split history records, Abeona Therapeutics has had 1 split.
ABEO split history picture
Abeona Therapeutics (ABEO) has 1 split in our ABEO split history database. The split for ABEO took place on July 05, 2022. This was a 1 for 25 reverse split, meaning for each 25 shares of ABEO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 40 share position following the split.

When a company such as Abeona Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the ABEO split history from start to finish, an original position size of 1000 shares would have turned into 40 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Abeona Therapeutics shares, starting with a $10,000 purchase of ABEO, presented on a split-history-adjusted basis factoring in the complete ABEO split history. ABEO split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 08/17/2012
End date: 08/15/2022
Start price/share: $11.75
End price/share: $4.65
Dividends collected/share: $0.00
Total return: -60.43%
Average Annual Total Return: -8.85%
Starting investment: $10,000.00
Ending investment: $3,958.83
Years: 10.00
Date Ratio
07/05/20221 for 25
ABEO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ABIO Split History
ABMD Split History
ABT Split History
ABV Split History
ACER Split History
ACET Split History
ACHC Split History
ACHV Split History
ACOR Split History
ACST Split History

Also explore: ABEO shares outstanding history

Email EnvelopeFree ABEO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Root, Inc. (ROOT)
Mind Medicine Inc. (MNED)
Greenlane Holdings, Inc. (GNLN)
U.S. Well Services, Inc. (USWS)
Nutriband Inc. (NTRB)
Exela Technologies, Inc. (XELA)
Motus GI Holdings, Inc. (MOTS)
Cellectar Biosciences, Inc. (CLRB)
Synthetic Biologics, Inc. (SYN)
McEwen Mining Inc. (MUX)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ABEO Insider Buying

ABEO Split History | www.SplitHistory.com | Copyright © 2013 - 2022, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.